Klebsiella pneumoniae O1 lipopolysaccharide (K. pneumoniae O1 LPS)

Klebsiella pneumoniae O1 lipopolysaccharide (LPS) is a complex glycolipid and a major virulence factor located in the outer membrane of O1-serotype Klebsiella pneumoniae, a pathogen frequently associated with hospital-acquired infections and liver abscesses (PMID: 28844975). The molecule consists of three distinct regions: the endotoxic Lipid A, a core oligosaccharide, and the O1-specific O-antigen, which is composed of D-galactan I and D-galactan II subunits (PMID: 30201714). Its primary biological function is to maintain the structural integrity of the bacterial cell and provide a defensive shield against host immune responses, such as complement-mediated lysis and antimicrobial peptides (PMID: 25155485). In the context of disease, the O1 LPS acts as a potent endotoxin, triggering systemic inflammatory responses through the activation of the TLR4/MD2 receptor complex, which can lead to septic shock (PMID: 23602592). As a therapeutic target, the O1-specific polysaccharide is utilized in the development of glycoconjugate vaccines and monoclonal antibodies aimed at providing targeted protection against the most prevalent clinical serotypes (PMID: 31615967). While traditional antibiotics like polymyxins target the Lipid A component of LPS to disrupt the membrane, they lack serotype specificity and are often used as a last resort due to toxicity. Current research focuses on neutralizing the O-antigen to enhance opsonophagocytosis and prevent the initial stages of bacterial colonization. Consequently, Klebsiella pneumoniae O1 LPS remains a critical focal point for both diagnostic serotyping and the engineering of next-generation antimicrobial strategies.

Other names

O1 antigenKlebsiella O1-LPSK. pneumoniae O1-specific polysaccharideEndotoxin O1

Binding and neutralization of the O-antigen to facilitate phagocytosis or prevent host cell interaction; disruption of the bacterial outer membrane via binding to the Lipid A component.